Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.5M Buy
5,810
+2,072
+55% +$3.59M 0.48% 40
2026
Q2
$7.44M Buy
3,738
+3,163
+550% +$5.03M 0.35% 38
2026
Q1
$759K Buy
575
+125
+28% +$171K 0.06% 61
2025
Q4
$481K Sell
450
-100
-18% -$104K 0.06% 64
2025
Q3
$532K Buy
550
+150
+38% +$118K 0.08% 56
2025
Q2
$321K Sell
400
-650
-62% -$466K 0.05% 60
2025
Q1
$696K Buy
1,050
+450
+75% +$327K 0.15% 50
2024
Q4
$416K Buy
+600
New +$431K 0.06% 58
2024
Q3
– Sell
-200
Closed -$205K – 62
2024
Q2
$205K Buy
+200
New +$192K 0.04% 58

Other funds holding ASML

Oak Grove Capital's ASML Position: Q3 2026 in Review

Oak Grove Capital increased its ASML (ASML) stake by 55% in Q3 2026, buying an estimated $3.59M and bringing the position to 5,810 shares worth $10.5M. The position accounts for 0.48% of the portfolio, ranked #40.

Oak Grove Capital first reported a position in ASML in Q2 2024 and has held it in 9 quarters since. 118 funds tracked by Wall St. Rank hold ASML as of Q3 2026.

  • Oak Grove Capital held 5,810 shares of ASML worth $10.5M as of Q3 2026.
  • Oak Grove Capital bought 2,072 ASML shares in Q3 2026, an estimated $3.59M.
  • ASML made up 0.48% of Oak Grove Capital's portfolio in Q3 2026, its #40 holding.
  • Oak Grove Capital first reported a position in ASML in Q2 2024 and has held it in 9 quarters since.
  • 118 funds tracked by Wall St. Rank held ASML as of Q3 2026.

Based on Oak Grove Capital's 13F filing for Q3 2026, filed 9 Oct 2026.